세계의 희귀질환 진단 시장 : 기술별, 용도별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Rare Disease Diagnostics Market size was valued at US$ 1,678.90 Million in 2024, expanding at a CAGR of 14.5% from 2025 to 2032.

The Rare Disease Diagnostics Market focuses on the development, production, and End-user of diagnostic tools and tests specifically designed to identify rare diseases, which affect a small percentage of the population. These diseases are often genetic, chronic, and complex, making early and accurate diagnosis crucial for effective treatment and management. The market includes various technologies such as genetic testing, molecular diagnostics, next-generation sequencing, and biochemical assays. Growth in this market is driven by increasing awareness of rare diseases, advancements in diagnostic technologies, and government initiatives promoting rare disease research.

Additionally, the rising number of rare disease patient registries and collaborations between healthcare providers and diagnostic companies support market expansion. Challenges include high costs of testing and limited access in developing regions. However, personalized medicine and innovations in artificial intelligence for diagnosis are expected to further boost market development. Overall, the Rare Disease Diagnostics Market plays a vital role in improving patient outcomes and supporting precision healthcare approaches.

Rare Disease Diagnostics Market- Market Dynamics

Growing adoption of advanced genetic testing technologies drives rare disease diagnostics market.

The growing adoption of advanced genetic testing technologies is a key driver for the Rare Disease Diagnostics Market. These technologies, including next-generation sequencing and whole-genome analysis, enable more precise and faster identification of rare genetic disorders that were previously difficult to diagnose. As a result, patients receive earlier and more accurate diagnoses, which significantly improves treatment outcomes and quality of life.

The advancement in genetic testing has also lowered costs and increased accessibility, encouraging wider use among healthcare providers and patients. Furthermore, innovations like non-invasive prenatal testing and liquid biopsies are expanding diagnostic possibilities. This technological progress is supported by increased research funding and regulatory approvals, fueling market growth. Overall, the integration of advanced genetic testing is transforming rare disease diagnostics, making it more effective and accessible globally.

Rare Disease Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2025-2032)

Based on Technology segmentation, Genetic Testing was predicted to show maximum market share in the year 2024

Based on application segmentation, Genetic Disorders was the leading application in 2024

Based on end-user segmentation, Hospitals and Clinics was the leading end-user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Rare Disease Diagnostics Market- Segmentation Analysis:

The Global Rare Disease Diagnostics Market is segmented on the basis of Technology, Application, End-user, and Region.

The market is divided into five categories based on Technology: Genetic Testing, Molecular Diagnostics, Next-Generation Sequencing (NGS), Biochemical Assays, and Immunoassays. Among the various technologies in the Rare Disease Diagnostics Market, Genetic Testing stands out as the most dominant segment. Genetic testing allows for the direct analysis of an individual's DNA to identify mutations or variations responsible for rare genetic disorders. This technology offers precise and early diagnosis, which is critical for managing diseases that are often complex and difficult to detect through traditional methods. Advances in genetic testing, including more affordable and rapid sequencing techniques, have increased its adoption among healthcare providers worldwide.

Moreover, genetic testing supports personalized medicine by enabling tailored treatment plans based on a patient's genetic profile. Its ability to diagnose a broad range of rare diseases, from inherited metabolic disorders to rare cancers, makes it indispensable. Additionally, growing awareness and government support have fueled the integration of genetic testing into routine clinical practice. The expansion of newborn screening programs and prenatal genetic tests further boosts its dominance in this market segment. Overall, genetic testing's accuracy, speed, and expanding applications firmly establish it as the leading technology in rare disease diagnostics.

The market is divided into five categories based on application: Genetic Disorders, Neurological Disorders, Metabolic Disorders, Rare Cancers, and Others. Genetic Disorders represent the most dominant application segment in the Rare Disease Diagnostics Market. These disorders are caused by abnormalities in an individual's DNA, often inherited from parents, making early and accurate diagnosis crucial for effective management. Genetic disorders cover a wide range of conditions, including cystic fibrosis, muscular dystrophy, and Huntington's disease, which significantly impact patient health and quality of life.

Diagnostic technologies such as genetic testing and next-generation sequencing are particularly effective in identifying these disorders by detecting specific gene mutations. Increased awareness among healthcare professionals and patients about the importance of early diagnosis has driven demand in this segment. Additionally, government initiatives and rare disease advocacy groups focus heavily on genetic disorders, supporting funding and research efforts. The growing availability of targeted therapies also enhances the need for precise genetic diagnosis. As genetic disorders often manifest early in life, newborn screening programs contribute to this segment's expansion. Overall, the need for accurate identification and personalized treatment options makes genetic disorders the leading application segment in rare disease diagnostics.

Rare Disease Diagnostics Market- Geographical Insights

North America holds a strong position in the Rare Disease Diagnostics Market due to its well-established healthcare infrastructure and significant investment in medical research. The region benefits from advanced diagnostic laboratories and widespread availability of cutting-edge technologies such as next-generation sequencing. Strong government support, including funding for rare disease research and patient advocacy programs, further strengthens the market landscape.

Collaboration between healthcare providers, research institutions, and diagnostic companies accelerates innovation and adoption of new diagnostic tools. Additionally, increased awareness about rare diseases among physicians and patients drives demand for early and accurate diagnosis. The presence of numerous rare disease patient registries and clinical trials also contributes to market growth. Overall, North America remains a key hub for advancements and commercialization in rare disease diagnostics, supported by a favorable regulatory environment and robust healthcare ecosystem.

The United States is a leading country in the Rare Disease Diagnostics Market, driven by its advanced healthcare system and strong focus on innovation. The country benefits from a high concentration of research institutions and biotechnology companies dedicated to developing new diagnostic technologies. Government agencies actively support rare disease initiatives through funding and regulatory frameworks that encourage faster approval of diagnostic tests. Additionally, patient advocacy groups in the U.S. play a crucial role in raising awareness and improving access to diagnostic services. The widespread adoption of cutting-edge genetic and molecular testing methods enhances the accuracy and speed of rare disease diagnosis.

Rare Disease Diagnostics Market- Competitive Landscape:

The Rare Disease Diagnostics Market is highly competitive, with key players focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a strong market presence. Companies like Illumina, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, and Bio-Rad Laboratories lead the market by investing heavily in research and development to improve diagnostic accuracy and speed.

Other significant players, such as Abbott Laboratories, Invitae Corporation, Myriad Genetics, and Natera, Inc., contribute through advanced genetic testing and molecular diagnostics solutions. The competition also involves collaborations with healthcare providers and academic institutions to accelerate rare disease research and diagnosis. Additionally, firms are working to enhance accessibility and reduce the costs of diagnostic tests to reach a broader patient base. This dynamic landscape drives continuous technological advancements and creates opportunities for emerging companies to enter the market.

Recent Developments:

In March 2025, Illumina launched the new MiSeq i100 gene sequencer aimed at making genetic sequencing more affordable and accessible to smaller laboratories worldwide.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL RARE DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Illumina, Inc.
• Thermo Fisher Scientific
• Roche Diagnostics
• QIAGEN N.V.
• Bio-Rad Laboratories
• Abbott Laboratories
• Becton, Dickinson and Company
• Invitae Corporation
• Agilent Technologies
• PerkinElmer, Inc.
• Myriad Genetics
• Natera, Inc.
• F. Hoffmann-La Roche AG
• Guardant Health
• Twist Bioscience Corporation
• Laboratory Corporation of America Holdings (LabCorp)
• Charles River Laboratories
• Sophia Genetics
• Centogene AG
• Blueprint Genetics

GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

• Genetic Testing
• Molecular Diagnostics
• Next-Generation Sequencing (NGS)
• Biochemical Assays
• Immunoassays

GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Genetic Disorders
• Neurological Disorders
• Metabolic Disorders
• Rare Cancers
• Others

GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals and Clinics
• Diagnostic Laboratories
• Research Institutes
• Academic and Government Research Centers

GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Rare Disease Diagnostics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Rare Disease Diagnostics Market Snippet by Technology
  • 2.1.2. Rare Disease Diagnostics Market Snippet by Application
  • 2.1.3. Rare Disease Diagnostics Market Snippet by End-user
  • 2.1.4. Rare Disease Diagnostics Market Snippet by Country
  • 2.1.5. Rare Disease Diagnostics Market Snippet by Region
• 2.2. Competitive Insights

3. Rare Disease Diagnostics Key Market Trends

• 3.1. Rare Disease Diagnostics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Rare Disease Diagnostics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Rare Disease Diagnostics Market Opportunities
• 3.4. Rare Disease Diagnostics Market Future Trends

4. Rare Disease Diagnostics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Rare Disease Diagnostics Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Rare Disease Diagnostics Market Landscape

• 6.1. Rare Disease Diagnostics Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Rare Disease Diagnostics Market - By Technology

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
  • 7.1.2. Genetic Testing
  • 7.1.3. Molecular Diagnostics
  • 7.1.4. Next-Generation Sequencing (NGS)
  • 7.1.5. Biochemical Assays
  • 7.1.6. Immunoassays

8. Rare Disease Diagnostics Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
  • 8.1.2. Genetic Disorders
  • 8.1.3. Neurological Disorders
  • 8.1.4. Metabolic Disorders
  • 8.1.5. Rare Cancers
  • 8.1.6. Others

9. Rare Disease Diagnostics Market - By End-user

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
  • 9.1.2. Hospitals and Clinics
  • 9.1.3. Diagnostic Laboratories
  • 9.1.4. Research Institutes
  • 9.1.5. Academic and Government Research Centers

10. Rare Disease Diagnostics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Rare Disease Diagnostics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Rare Disease Diagnostics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.8. UK
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.9. France
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.10. Italy
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.11. Spain
    • 10.3.11.1. Overview
    • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.12. The Netherlands
    • 10.3.12.1. Overview
    • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Overview
    • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.14. Russia
    • 10.3.14.1. Overview
    • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.15. Poland
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3.16. Rest of Europe
    • 10.3.16.1. Overview
    • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Rare Disease Diagnostics Key Manufacturers in Asia Pacific
  • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.7. China
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.8. India
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.12. Indonesia
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.13. Thailand
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.5. Latin America (LATAM)
  • 10.5.1. Overview
  • 10.5.2. Rare Disease Diagnostics Key Manufacturers in Latin America
  • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa (MEA)
  • 10.6.1. Overview
  • 10.6.2. Rare Disease Diagnostics Key Manufacturers in Middle East and Africa
  • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.8. UAE
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Rare Disease Diagnostics Industry

• 11.1. Competitive Dashboard
  • 11.1.1. Competitive Benchmarking
  • 11.1.2. Competitive Positioning
• 11.2. Company Profiles
  • 11.2.1. Illumina, Inc.
  • 11.2.2. Thermo Fisher Scientific
  • 11.2.3. Roche Diagnostics
  • 11.2.4. QIAGEN N.V.
  • 11.2.5. Bio-Rad Laboratories
  • 11.2.6. Abbott Laboratories
  • 11.2.7. Becton, Dickinson and Company
  • 11.2.8. Invitae Corporation
  • 11.2.9. Agilent Technologies
  • 11.2.10. PerkinElmer, Inc.
  • 11.2.11. Myriad Genetics
  • 11.2.12. Natera, Inc.
  • 11.2.13. F. Hoffmann-La Roche AG
  • 11.2.14. Guardant Health
  • 11.2.15. Twist Bioscience Corporation
  • 11.2.16. Laboratory Corporation of America Holdings (LabCorp)
  • 11.2.17. Charles River Laboratories
  • 11.2.18. Sophia Genetics
  • 11.2.19. Centogene AG
  • 11.2.20. Blueprint Genetics

12. 360 Degree AnalystView

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us